Pharmaco-epidemiological Study Describing a Population of Hypertensive Patients Treated With a Fixed-dose Combination of Telmisartan and Hydrochlorothiazide

NCT02248129 · clinicaltrials.gov ↗

COMPLETED

Status

4255

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Telmisartan and hydrochlorothiazide

Sponsor

Boehringer Ingelheim